Pharmacological management of sleep-disordered breathing

J. Hedner, D. Zou

Source: Eur Respir Monogr 2010; 50: 321-339
Journal Issue: Sleep Apnoea out of print
Disease area: Sleep and breathing disorders

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Hedner, D. Zou. Pharmacological management of sleep-disordered breathing. Eur Respir Monogr 2010; 50: 321-339

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Sleep, sleep-disordered breathing and metabolic consequences
Source: Eur Respir J 2009; 34: 243-260
Year: 2009

Treatment effects of sleep apnoea: where are we now?
Source: Eur Respir Rev 2007; 16: 146-168
Year: 2007

Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Source: Eur Respir J 2013; 41: 523-538
Year: 2013

Atypical patterns in portable monitoring for sleep apnoea: features of nocturnal epilepsy?
Source: Eur Respir J 2013; 41: 368-375
Year: 2013

Weight-loss treatment for OSA: medical and surgical options
Source: Eur Respir Mon 2010; 50: 302-320
Year: 2010

Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives
Source: Eur Respir J 2008; 32: 1082-1095
Year: 2008

Sleep apnoea and systemic hypertension
Source: Eur Respir Mon 2010; 50: 150-173
Year: 2010

Hormonal replacement therapy in sleep-disordered breathing
Source: Annual Congress 2007 - Gender-related aspects in sleep apnoea
Year: 2007

Pathophysiology of central sleep apnea
Source: Annual Congress 2005 - Central sleep apnoea
Year: 2005

Outcomes of OSA and indications for different therapies
Source: Eur Respir Mon 2010; 50: 225-243
Year: 2010

Compliance in sleep apnoea therapy: influence of home care support and pressure mode
Source: Eur Respir J 2009; 33: 804-811
Year: 2009

Sex differences in obstructive sleep apnoea in an elderly French population
Source: Eur Respir J 2011; 37: 1137-1143
Year: 2011

Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea
Source: Eur Respir J 2012; 39: 1136-1143
Year: 2012

Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study
Source: Eur Respir J 2013; 41: 360-367
Year: 2013

Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016

Obstructive sleep apnoea and its association with gestational hypertension
Source: Eur Respir J 2009; 33: 559-565
Year: 2009

Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006

Clinical implications of residual sleep apnoea after chronic CPAP therapy
Source: Breathe 2011; 7: 289-290
Year: 2011

Impact of obstructive sleep apnoea (OSA) on glucose metabolism
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007

Treatment of obstructive and central sleep apnoea in heart failure: current concepts and perspectives
Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives
Year: 2005